Dexcom | DXCM - Los Gastos De Explotación

Precio De Mercado
61.57
Cambio Diario
-1.13 -1.80%
Mensual
-7.88%
Anual
-14.08%
Q2 Expectativa
60.25




Los Gastos De Explotación Cambio Fecha
Abbott USD 9.31B 104M 2026-03
Align Technology USD 822.85M 11.8M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 17.44B 1.53B 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 1.89B 3.09B 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
West Pharmaceutical Services USD 2.99B 2.35B 2026-03
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12